Related Experiment Video
Updated: Jun 29, 2025
Induction and Micro-CT Imaging of Cerebral Cavernous Malformations in Mouse Model
Published on: September 4, 2017
Clinical Features and Treatment of Pediatric Cerebral Cavernous Malformations
1Division of Pediatric Neurosurgery, Seoul National University Children's Hospital, Seoul National University College of Medicine, Seoul, Korea.
Insights
Cerebral cavernous malformations (CCM) in children often present with neurological symptoms. Understanding CCM natural history is key, as initial presentation impacts future hemorrhage risk.
Area of Science:
- Neurology
- Pediatric Vascular Neurology
Background:
- Cerebral cavernous malformations (CCMs) are vascular anomalies prevalent in pediatric populations.
- Clinical manifestations in children include headaches, seizures, and focal neurological deficits, though 40% remain asymptomatic.
Purpose of the Study:
- To elucidate the natural history and treatment strategies for pediatric cerebral cavernous malformations.
- To highlight the importance of understanding hemorrhage risk based on initial presentation.
Main Methods:
- Review of existing literature on pediatric CCMs, focusing on natural history, clinical presentation, and treatment outcomes.
- Analysis of hemorrhage rates in relation to initial presentation (symptomatic vs. asymptomatic).
Main Results:
- Hemorrhagic rates are significantly higher in pediatric patients with a history of symptomatic presentation compared to asymptomatic individuals.
- Temporal clustering of hemorrhages is observed, with increased frequency within years of an initial hemorrhagic event.
- Surgical resection is the primary treatment, though the benefit of excising hemosiderin rims for epilepsy is debated.
Conclusions:
- Understanding the natural history of pediatric CCMs is critical for risk stratification and management.
- Surgical resection is standard, but further clinical trials are needed to validate stereotactic radiosurgery for deep-seated CCMs.
Abstract:
Cerebral cavernous malformation (CCM) is a vascular anomaly commonly found in children and young adults. Common clinical presentations of pediatric patients with CCMs include headache, focal neurological deficits, and seizures. Approximately 40% of pediatric patients are asymptomatic. Understanding the natural history of CCM is crucial and hemorrhagic rates are higher in patients with an initial hemorrhagic presentation, whereas it is low in asymptomatic patients. There is a phenomenon known as temporal clustering in which a higher frequency of symptomatic hemorrhages occurs within a few years following the initial hemorrhagic event. Surgical resection remains the mainstay of treatment for pediatric CCMs. Excision of a hemosiderin-laden rim is controversial regarding its impact on epilepsy outcomes. Stereotactic radiosurgery is an alternative treatment, especially for deepseated CCMs, but its true efficacy needs to be verified in a clinical trial.
